The 21st Edition ‘Strategic Project & Portfolio Management for Pharma’ is a marcus evans unique event taking place virtually on the 17th-18th of June 2021, bringing you closer to solutions in PPM at a time of great opportunity for change and great pressure on R&D PPM functions. By attending this event you will discuss practical approaches to aligning R&D and Portfolio Strategy and how to better manage disruptions, prioritization and reprioritization. You will engage in discussions with your peers on how to motivate your organisation to invest in long-term planning and capacity management, and how to create a non-bureaucratic, agile way of working in PPM. Join us for two exciting days of practical case studies and debate!
Expert Speaker Panel includes:
- Thorsten Knoechel, Head of Project Management Methodology Biopharma | R&D Strategy and Business Operations, Merck
- Mandy Crowther, Head of Early Oncology Project Management, Astrazeneca
- Stephen Cho, Global Head, Portfolio Management & Learning, Novartis Institutes for Biomedical Research
- Daria Mikhailova, Senior Manager Portfolio Intelligence, STADA
- Ulrike Rauh, Senior Manager, Global Portfolio Management, Bayer AG
- Kevin Magalhaes, Associate Director, Program Management, Blueprint Medicines
- Magnus Ytterstad, VP of Customer Success and Analytics, Captario
Event Name: 21st Edition Strategic Project & Portfolio Management for Pharma
Event Venue: Virtual Event
Event Date: 17-18 June, 2021
Event Website Link: https://www.marcusevans.com/conferences/strategicppmforpharma
Event Organizer Name: marcus evans
Communication number (with country & area code): +357 22 849404
Email ID: riak@marcusevanscy.com
Social Media Links:
https://twitter.com/marcusevans
https://linkedin.com/company/marcusevansgroup/
https://www.facebook.com/marcusevansGroup/
